1. Home
  2. ANNX vs LXU Comparison

ANNX vs LXU Comparison

Compare ANNX & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.36

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$12.48

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
LXU
Founded
2011
1968
Country
United States
United States
Employees
N/A
513
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
1.0B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
ANNX
LXU
Price
$5.36
$12.48
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$16.50
$14.63
AVG Volume (30 Days)
2.1M
965.5K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
225.93
EPS
N/A
0.27
Revenue
N/A
$615,208,000.00
Revenue This Year
N/A
$13.69
Revenue Next Year
$16,320.74
N/A
P/E Ratio
N/A
$47.89
Revenue Growth
N/A
17.77
52 Week Low
$1.85
$7.09
52 Week High
$7.18
$17.22

Technical Indicators

Market Signals
Indicator
ANNX
LXU
Relative Strength Index (RSI) 48.41 36.89
Support Level $4.80 $8.15
Resistance Level $5.61 $15.56
Average True Range (ATR) 0.28 0.68
MACD 0.02 -0.19
Stochastic Oscillator 55.96 0.16

Price Performance

Historical Comparison
ANNX
LXU

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: